| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Turn Therapeutics Inc. (TTRX) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. TTRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 15.72M | $59.64M | - | |
| Other | 1.45M | $5.49M | - | |
| Dir | 360.6K | $1.37M | - | |
| Other | 80.0K | $303.6K | - | |
| Dir | 21.9K | $83.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Chaudhary Zuraiz50 | See Remarks | Buy | 2,500 | $3.50 | $8,750.00 | +25.0% | +9.2% | - | |
| Nov 24, 2025 | Golden Arthur F67 | Director | Buy | 9,868 | $3.44 | $33,945.92 | +19.5% | -1.7% | - | |
| Nov 21, 2025 | Golden Arthur F67 | Director | Buy | 20,532 | $2.87 | $58,926.84 | +68.0% | +4.0% | - | |
| Nov 21, 2025 | Chaudhary Zuraiz50 | See Remarks | Buy | 2,450 | $2.89 | $7,074.50 | +14.8% | +4.0% | - | |
| Nov 17, 2025 | Chaudhary Zuraiz50 | See Remarks | Buy | 2,500 | $3.62 | $9,050.00 | +49.5% | -8.6% | - | |
| Oct 23, 2025 | Chesed Abraham | Board Observer | Buy | 14,286 | $4.60 | $65,715.60 | +1.0% | -6.3% | - | |
| Oct 23, 2025 | Chaudhary Zuraiz50 | See Remarks | Buy | 5,050 | $4.95 | $24,997.50 | New | -6.3% | - | |
| Oct 23, 2025 | Golden Arthur F67 | Director | Buy | 20,202 | $4.95 | $99,999.90 | +202.0% | -6.3% | - |